Showing 1–25 of 110 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Mary A. Alex-Wele, Nneka Onyejepu, Orikomaba Obunge
…currently listed among the 30 high burden countries for TB, TB/HIV and DR-TB. This study was carried out to determine Mycobacterium tuberculosis resistance pattern to first-line anti-TB drugs (rifampicin and isoniazid) in TB patients who were HIV seropositive in Rivers State. <h3…
Sekossounon Sanni, Ablo Prudence Wachinou, Corinne Simone Colette Merle, Kossi Wilfried Bekou, Marius Esse, et al.
…own to be more effective for tuberculosis (TB) treatment in TB/HIV co-infected patients. This study assessed the hepatic safety of a high-dose Rifampicin regimen among TB/HIV co-infected patients. 811 TB/HIV co-infected patients, antiretroviral treatment (ART) naïve, at leas…
Rossetto M, Brand ÉM, Rodrigues RM, Serrant L, Teixeira LB
…for the occurrence of hospitalization and death in cases of TB/HIV co-infection in the south of Brazil. The data are taken from a population-based retrospective cohort study on cases of TB/HIV co-infection from 2009 to 2013 in Porto Alegre, Brazil. Sociodemographic, epidemiologic…
de Colombani, Pierpaolo, Banatvala, Nicholas, Zaleskis, Richard, Maher, Dermot
…g dramatically in eastern Europe. HIV-related tuberculosis (TB/HIV) morbidity and mortality are expected to accelerate significantly in the future. This framework aims to guide European countries in developing their national plan for reducing TB/HIV morbidity and mortality. It re…
Seid A, Girma Y, Abebe A, Dereb E, Kassa M, et al.
…llenges global TB control and prevention efforts, where the TB/HIV co-infection epidemic makes the situation much worse. The aim of the study was to determine the determinant factors associated with patterns of MDR-TB among pulmonary TB patients in the Northwest Amhara, Ethiopia.…
Stop TB Partnership. Working Group on DOTS Expansion. Meeting (2005 : Versailles, France), Stop TB Partnership, World Health Organization, Stop TB Partnership. Working Group on TB/HIV. Meeting (2005 : Versailles, France), Stop TB Partnership. Working Group on DOTS-Plus for MDR-TB. Meeting (2005 : Versailles, France)
Mishkin K, Alaei K, Alikeyeva E, Paynter C, Aringazina A, et al.
Objectives Drug-resistant tuberculosis (TB) poses a serious threat to public health in Kazakhstan. This paper presents findings related to TB treatment outcome and drug resistance status among people co-infected with human immunodeficiency virus (HIV) and TB in Kazakhstan. Method…
World Health Organization
Dmytro Butov, MD
Treatment of multidrug-resistant TB (MDR-TB) is 100 times more expensive than treatment of drug-susceptible TB, requiring intensive clinical management for prolonged time (18-24 months) and more toxic treatment course. In prior open label study the investigators have shown that a…
Stop TB Initiative
Torpey K, Agyei-Nkansah A, Ogyiri L, Forson A, Lartey M, et al.
Tuberculosis (TB) and HIV are strongly linked. There is a 19 times increased risk of developing active TB in people living with HIV than in HIV-negative people with Sub-Saharan Africa being the hardest hit region. According to the WHO, 1.3 million people died from TB, and an addi…
Theresa Musa Hassab, Audrey Hamachila, Aubrey Chichonyi Kalungia, Norman Nyazema, Moses Mukosha, et al.
Tuberculosis (TB) and HIV co-infection pose significant challenges in resource-limited settings, contributing to multi-drug-resistant TB when treatment fails. This study aimed to identify determinants of TB treatment outcomes among HIV/TB co-infected patients in Lusaka, Zambia.A …
Bionghi N, Daftary A, Maharaj B, Msibi Z, Amico KR, et al.
…e-containing TB regimens. Methods Eligible patients were DR-TB/HIV co-infected adults hospitalized for the initiation of Bedaquiline-containing treatment regimens in KwaZulu-Natal, South Africa. A one-way crossover design was used to evaluate levels of adherence and patient accep…
Э.Б. Цыбикова, В В Пунга, Larisa Rusakova
The objective of the study is to analyze TB/HIV co-infection situation in the regions of RF and to identify correlated epidemiological rates. Subjects and methods . The data from Rosstat Forms no. 61, 8 and 33 were used as well as Rosstat data on the number of population for 2017…
Milyausha M. Yunusbaeva, L. Ya. Borodinа, Р. А. Шарипов, E. S. Bilalov, M. M. Аzamatova, et al.
…alence of multiple drug resistant tuberculosis (MDR TB) and TB/HIV coinfection (TB/HIV) in Volga Federal District (VFD) and its regions during 2016-2020. Subjects and Methods. Data from FGSN Forms No. 8, 33, and 61, and analytical reviews of main statistical TB rates in the Russi…
O. M. Immanuel, A. Omega-Immanuel, A. I. Isaiah
…-poor setting. This study aimed to assess the prevalence of TB/HIV co-infection among HIV suspects accessing care at Niger Delta University Teaching Hospital (NDUTH), Okolobiri, Yenagoa, Bayelsa State, Nigeria. The survey was conducted from July to December 2023. The study popula…
Azeez A, Ndege J, Mutambayi R
… and the contributing factors of unsuccessful results among TB/HIV patients. A retrospective cohort study of all confirmed adult TB/HIV coinfected hospitalized patients with drug-resistant TB reported for the treatment in two different hospitals from 2010 to 2016 in Eastern Cape,…
С. Н. Жданова, О. Б. Огарков, Scott K. Heysell
…oving the compliance of patients with tuberculosis and HIV (TB/HIV). Materials and methods. Piloted clinic-affiliated mobile intervention was carried out in 54 patients with TB/HIV and with a history of psychoactive substances abuse in Irkutsk Regional Clinical Tuberculosis Hospi…
J Wallenfels, M Malý
… cases were screened for HIV. The mean age of patients with TB/HIV coinfection was 35 years. The largest number of coinfected persons (35 cases) were from the capital city of Prague. Pulmonary TB was detected in 84 cases. Ninety-two per cent of the TB cases were bacteriologically…
Wallenfels J, Malý M
… cases were screened for HIV. The mean age of patients with TB/HIV coinfection was 35 years. The largest number of coinfected persons (35 cases) were from the capital city of Prague. Pulmonary TB was detected in 84 cases. Ninety-two per cent of the TB cases were bacteriologically…
Kraef C, Bentzon A, Roen A, Bolokadze N, Thompson M, et al.
…es TB recurrence, mortality rates and causes of death among TB/HIV patients from Eastern Europe up to 11 years after TB diagnosis. Methods A longitudinal cohort study of TB/HIV patients enrolled between 2011 and 2013 (at TB diagnosis) and followed-up until end of 2021. A competin…
Mary A. Alex- Wele, Nneka Onyejepu, Orikomaba Obunge
…currently listed among the 30 high burden countries for TB, TB/HIV and drug resistant TB (DR-TB). The current study assessed the resistant patterns of Mycobacterium tuberculosis to first-line anti-TB drugs among individuals with tuberculosis and HIV coinfection in Rivers State.&#…
Yang J, Zheng X, Zhang S, Wang H
…rovide a reference for clinical screening and prevention of TB/HIV dual infection. TB patients and HIV-infected/AIDS patients registered in Fuzhou Center for Disease Control and Prevention were selected as research subjects. The population characteristics of TB/HIV dual infection…
Mesfin EA, Beyene D, Tesfaye A, Admasu A, Addise D, et al.
…previously treated for tuberculosis, while 128 (56.6%) were TB/HIV co-infected. A majority [122 (54%)] of the isolates were resistant to any first-line anti-TB drugs. Among the resistant isolates, 110 (48.7%) were determined to be resistant to isoniazid, 94 (41.6%) to streptomyci…
Arth Nana, Nitipatana Chierakul
…ist of the 30 countries with both a high TB burden and high TB/HIV burden. Thailand has implemented the policy of TB screening among high-risk groups, for example household contacts, diabetic patients, elderly people, migrant workers, healthcare workers, prisoners and patients wi…